HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1.

AuthorsAmit A Kulkarni, Ganesh Boora, Rahul Kanwar, Kathryn J Ruddy, Michaela S Banck, Nguyet Le-Lindqwister, Terry M Therneau, Charles L Loprinzi, Andreas S Beutler
JournalActa oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 54 Issue 8 Pg. 1227-9 ( 2015) ISSN: 1651-226X [Electronic] England
PMID25549536 (Publication Type: Letter, Research Support, N.I.H., Extramural)
Chemical References
  • Antineoplastic Agents
  • Extracellular Matrix Proteins
  • GPI-Linked Proteins
  • RWDD3 protein, human
  • TECTA protein, human
  • Transcription Factors
  • Paclitaxel
Topics
  • Antineoplastic Agents (adverse effects)
  • Extracellular Matrix Proteins (genetics)
  • GPI-Linked Proteins (genetics)
  • Genotype
  • Humans
  • Paclitaxel (adverse effects)
  • Peripheral Nervous System Diseases (chemically induced, genetics)
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide
  • Transcription Factors (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: